Literature DB >> 14510915

Circulating resistin levels in essential hypertension.

Masato Furuhashi1, Nobuyuki Ura, Katsuhiro Higashiura, Hideyuki Murakami, Kazuaki Shimamoto.   

Abstract

OBJECTIVE: Resistin, a novel cysteine-rich protein secreted by adipocytes, has been proposed to serve as a link between obesity and insulin resistance in rodents, but this has remained controversial. Most of the data obtained in previous studies are restricted to mRNA levels in tissues. DESIGN AND PATIENTS: We examined the association between insulin resistance and circulating protein levels of resistin in 33 essential hypertensive patients (EHT) and 18 normotensive subjects (NT). Insulin sensitivity (M-value) was evaluated by the euglycaemic hyperinsulinaemic glucose clamp technique.
RESULTS: Using a cutoff point of mean - 1 SD of the M-value in the NT, the EHT were divided into two groups: one group of 12 insulin-resistant patients (EHT-R) and one group of 21 noninsulin-resistant patients (EHT-N). There were no intergroup differences in age, gender, body mass index (BMI; range: 20.1-30.4 kg/m2), fasting glucose and total cholesterol. The EHT-R had significantly higher levels of fasting insulin and triglyceride than did the NT and the EHT-N. The EHT-R had higher levels of free fatty acid and lower levels of high-density lipoprotein cholesterol than did the EHT-N. The M-value was negatively correlated with fasting insulin, free fatty acid, and triglyceride. Circulating resistin levels were not significantly different among the three groups and were not correlated with the M-value, BMI, blood pressure, or lipid variables.
CONCLUSIONS: Our results suggest that circulating resistin levels are not related to insulin resistance, at least in patients with essential hypertension, although disturbance of lipid metabolism may be associated with insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14510915     DOI: 10.1046/j.1365-2265.2003.01879.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  9 in total

1.  Plasma resistin levels associate with risk for hypertension among nondiabetic women.

Authors:  Luxia Zhang; Gary C Curhan; John P Forman
Journal:  J Am Soc Nephrol       Date:  2010-04-08       Impact factor: 10.121

2.  Distinct vascular and metabolic effects of different classes of anti-hypertensive drugs.

Authors:  Kwang Kon Koh; Michael J Quon; Seung Hwan Han; Yonghee Lee; Soo Jin Kim; Yesl Koh; Eak Kyun Shin
Journal:  Int J Cardiol       Date:  2008-12-06       Impact factor: 4.164

3.  Association of adulthood weight gain with circulating adipokine and insulin resistance in the Japanese population.

Authors:  Y Kimura; N M Pham; K Yasuda; A Nanri; K Kurotani; K Kuwahara; S Akter; M Sato; H Hayabuchi; T Mizoue
Journal:  Eur J Clin Nutr       Date:  2014-12-03       Impact factor: 4.016

4.  Association between adipocytokines and insulin resistance in Indian hypertensive patients.

Authors:  Sujata R Mahadik
Journal:  Indian Heart J       Date:  2012-03-26

5.  Adiponectin and resistin plasma levels in healthy individuals with prehypertension.

Authors:  Dimitrios P Papadopoulos; Thomas K Makris; Panagiota G Krespi; Maria Poulakou; Georgios Stavroulakis; Antonios N Hatzizacharias; Despina Perrea; Vasilios V Votteas
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-12       Impact factor: 3.738

6.  Association of circulating resistin with metabolic risk factors in Indian females having metabolic syndrome.

Authors:  V Gupta; A K Singh; Vani Gupta; S Kumar; N Srivastava; T Jafar; A B Pant
Journal:  Toxicol Int       Date:  2011-07

Review 7.  Association between serum resistin concentration and hypertension: A systematic review and meta-analysis.

Authors:  Yuxiang Zhang; Yixing Li; Lin Yu; Lei Zhou
Journal:  Oncotarget       Date:  2017-06-20

8.  Masked hypertension and atherogenesis: the impact on adiponectin and resistin plasma levels.

Authors:  Dimitris P Papadopoulos; Despina Perrea; Costas Thomopoulos; Elias Sanidas; Maria Daskalaki; Urania Papazachou; V Votteas; Thomas Makris
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-02       Impact factor: 3.738

Review 9.  Resistin, an Adipokine with Non-Generalized Actions on Sympathetic Nerve Activity.

Authors:  Emilio Badoer; Samin Kosari; Martin J Stebbing
Journal:  Front Physiol       Date:  2015-11-10       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.